Progestasert: a uterine therapeutic system for long-term contraception: I. Philosophy and clinical efficacy.

Suppr

超能文献

作者信息

Pharriss B B, Erickson R, Bashaw J, Hoff S, Place V A, Zaffaroni A

出版信息

Fertil Steril. 1974 Nov;25(11):915-21. doi: 10.1016/s0015-0282(16)40748-x.

DOI:10.1016/s0015-0282(16)40748-x

PMID:4426403

Abstract

摘要

相似文献

Progestasert: a uterine therapeutic system for long-term contraception: I. Philosophy and clinical efficacy.

Fertil Steril. 1974 Nov;25(11):915-21. doi: 10.1016/s0015-0282(16)40748-x.

Clinical experience with the uterine progesterone system (Progestasert R).子宫内孕酮系统（Progestasert R）的临床经验。

Contraception. 1976 May;13(5):559-69. doi: 10.1016/0010-7824(76)90012-3.

[Steroid intra-uterine contraception: progesterone-releasing devices. II. Insertion, clinical problems and contraceptive dependability].[甾体宫内避孕：释放孕酮的装置。II. 放置、临床问题及避孕可靠性]

Patol Clin Ostet Ginecol. 1984 Jul-Aug;12(4):331-43.

Intrauterine devices containing progesterone.

Drug Ther (NY). 1977 May;7(5):119-21.

Uterine therapeutic system for long-term contraception: II. Clinical correlates.用于长效避孕的子宫治疗系统：II. 临床关联

Fertil Steril. 1974 Nov;25(11):922-6.

Reversible contraception for the woman over 35 years of age.35岁以上女性的可逆性避孕方法。

Curr Opin Obstet Gynecol. 1992 Dec;4(6):891-6.

Effects of a progesterone-releasing intrauterine contraceptive device on endometrial blood vessels: a morphometric study.含孕激素宫内节育器对子宫内膜血管的影响：一项形态计量学研究。

Am J Obstet Gynecol. 1981 Dec 1;141(7):821-7. doi: 10.1016/0002-9378(81)90711-0.

Serum cortisol level in lactating women using Progestasert system.使用普洛歇赛特系统的哺乳期妇女的血清皮质醇水平。

Popul Sci. 1981(2):109-14.

Lactation pattern in Egyptian women using the Progestasert system.使用炔诺孕酮宫内节育系统的埃及女性的泌乳模式。

Contracept Deliv Syst. 1982 Jan;3(1):53-60.

Progress in the development of the Progestasert TM 65 progesterone therapeutic system for contraception.用于避孕的普洛杰斯特 TM 65 孕酮治疗系统的研发进展。

J Reprod Med. 1974 Aug;13(2):66-8.

引用本文的文献

Utility of the Levonorgestrel-Releasing Intrauterine System in the Treatment of Abnormal Uterine Bleeding and Dysmenorrhea: A Narrative Review.左炔诺孕酮宫内节育系统在治疗异常子宫出血和痛经中的应用：一项叙述性综述。

J Clin Med. 2022 Oct 1;11(19):5836. doi: 10.3390/jcm11195836.

Development of Hormonal Intravaginal Rings: Technology and Challenges.激素阴道环的研发：技术与挑战

Geburtshilfe Frauenheilkd. 2021 Jul;81(7):789-806. doi: 10.1055/a-1369-9395. Epub 2021 Jul 13.

Thirty years of mirena: A story of innovation and change in women's healthcare.三十载米乐娜：妇女生殖健康领域的创新与变革。

Acta Obstet Gynecol Scand. 2021 Apr;100(4):614-618. doi: 10.1111/aogs.14110. Epub 2021 Feb 23.

Nanoparticle- and Nanoporous-Membrane-Mediated Delivery of Therapeutics.纳米颗粒和纳米多孔膜介导的治疗药物递送

Pharmaceutics. 2019 Jun 21;11(6):294. doi: 10.3390/pharmaceutics11060294.

Levonorgestrel-IUS system and endometrial manipulation.左炔诺孕酮宫内缓释系统与子宫内膜操作

J Midlife Health. 2013 Jan;4(1):6-7. doi: 10.4103/0976-7800.109625.

Poly(lactide-co-glycolide) nanoparticle assembly for highly efficient delivery of potent therapeutic agents from medical devices.聚（丙交酯-乙交酯）纳米粒子组装用于从医疗器械高效递药的强效治疗剂。

Biomaterials. 2010 May;31(13):3631-42. doi: 10.1016/j.biomaterials.2010.01.048. Epub 2010 Feb 10.

Benefit-risk assessment of the levonorgestrel intrauterine system in contraception.左炔诺孕酮宫内节育系统用于避孕的获益-风险评估。

Drug Saf. 2004;27(15):1185-204. doi: 10.2165/00002018-200427150-00003.

Controlled-release delivery systems for hormones. A review of their properties and current therapeutic use.激素控释给药系统。其特性及当前治疗应用综述。

Drugs. 1984 Jun;27(6):528-47. doi: 10.2165/00003495-198427060-00002.

[The histological reaction of the endometrium to gestagens applied locally].[子宫内膜对局部应用孕激素的组织学反应]

Virchows Arch A Pathol Anat Histol. 1975 Nov 28;368(4):289-98. doi: 10.1007/BF00432307.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验